… Dr. Sumanta (Monty) Kumar Pal, M.D., FASCO highlights some of the top data and presentations being presented in kidney and…
Browsing: Bladder
Introduction The US Food and Drug Administration (FDA) recently approved nogapendekin alfa inbakicept-pmln (Anktiva), used in conjunction with bacillus Calmette-Guérin…
By: Thomas Powles, MD Date: October 25, 2023 An exclusive interview occurred with Dr. Thomas Powles, MD, the lead investigator…
an AML-ALL US Focus Meeting 2023 video
Mark Schoenberg, MD- UrologyGenitourinary (GU) CancerBladder Cancer-The Montefiore Medical Center and The Albert Einstein College of Medicine at UroGen Pharma…
Nataliya Mar, MD Clinical Associate Professor in the Division of Hematology/Oncology at the University of California Irvine, provides GU ASCO…
Akasha Dukkipati, MD at City of Hope August 21, 2023 Akasha Dukkipati, MD at City of Hope, conducted an analysis…
In the ever-evolving world of oncology, there is always a beacon of hope on the horizon. The latest such promise…
Infigratinib, an FGFR1-3 inhibitor, has shown promise as an adjuvant therapy for invasive urothelial carcinoma. The FDA has approved infigratinib…
Manojkumar Bupathi, MD, from the Rocky Mountain Cancer Centers, conducted a study to evaluate the effectiveness of sacituzumab govitecan (SG)…
Manojkumar Bupathi, MD, MS, from Rocky Mountain Cancer Centers, conducted a safety analysis on cohort 1 of the TROPHY-U-01 phase…
Advanced Urothelial carcinoma, primarily affecting the urinary system, is a typically aggressive cancer with limited treatment options. Pembrolizumab, an immunotherapy…
Patrizia Giannatempo, MD, from the Fondazione IRCCS Istituto Nazionale dei Tumori, has conducted extensive research on the impact of histology…
Petros Grivas, MD, PhD, an expert in urothelial carcinoma (UC) research at the University of Washington, has made significant contributions…
Bladder Cancer Test: Does GALEAS Bladder aid in the early detection of bladder cancers? Prof. Bryan Dr. Ward Professor…
Bladder cancer test called “GALEAS Bladder” is a DNA-based diagnostic urine test designed to aid in the early detection of…
iFrame is not supported! Pembrolizumab combined with CG0070. How can this help patients with NMIBC? Roger Li Roger Li, MD…
The Roger Li, MD discussed the updated results from the CORE1 trial, which explored the combination of Cretostimogene Grenadorepvec (CG0070),…
Urothelial Cancer: What’s New in 2023? Targeted and Novel Therapies Nataliya Mar MD By Nataliya Mar, MD Good afternoon, everyone.…
rAd-IFNα/Syn3 Phase 3 Trial NMIBC [2022] rAd-IFNα/Syn3 Bladder Cancer Trial It’s an honor to be asked to speak about…
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video…
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video…
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video…
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video…
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video…
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video…
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video…
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video…
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video…
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video…
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video…
We are excited to bring new and updated information to share through our Bladder Cancer Video Library. For this video…
Roger Li, MD, Genitourinary Oncologist at Moffitt Cancer Center. In this video, he speaks about ASCO 2022 abstract CORE1: Phase…
Roger Li, MD, Genitourinary Oncologist at Moffitt Cancer Center. In this video, he speaks about ASCO 2022 abstract CORE1: Phase…
Karim Chamie, MD, Associate Professor of Urology and Society of Urologic Oncology Fellowship Director at UCLA Health. In this video,…
Karim Chamie, MD, Associate Professor of Urology and Society of Urologic Oncology Fellowship Director at UCLA Health. In this video,…
Gary Winzelberg, MD, MPH, Associate Professor, Division of Geriatric Medicine, Associate Director, UNC Palliative Care Program, Director, Hospice, and Palliative…
Gary Winzelberg, MD, MPH, Associate Professor, Division of Geriatric Medicine, Associate Director, UNC Palliative Care Program, Director, Hospice, and Palliative…
William C. Huang, M.D., FACS, Associate Professor and Vice-Chair of Urology at NYU Langone Health, Principal Investigator of the OPTIMA…
Peter H. O’Donnell, MD from the University of Chicago speaks about the ASCO 2021 Abstract – Oral Abstract Session: First-Line…
Jennifer Linehan, M.D., Associate Professor of Urology and Urologic Oncology at Saint John’s Cancer Institute, Investigator of the OLYMPUS trial…
Jennifer Linehan, M.D., Associate Professor of Urology and Urologic Oncology at Saint John’s Cancer Institute, Investigator of the OLYMPUS trial…
Peter H. O’Donnell, MD from the University of Chicago speaks about the ASCO 2021 Abstract – Oral Abstract Session: First-Line…
Petros Grivas, MD, Ph.D. Department Of Medicine, Division Of Medical Oncology, University of Washington; Fred Hutchinson Cancer Research Center, and…
Professor Thomas Powles, MD from Barts Cancer Centre, London, UK speaks about European Commission Approves BAVENCIO® (avelumab) for First-Line Maintenance…
Professor Thomas Powles, MD of Barts Cancer Centre, Queen Mary University of London speaks about Seattle Genetics and Astellas Announce…
Arjun Balar, MD from NYU Langone’s Perlmutter Cancer Center discusses Astellas and Seagen Announce Positive Topline Results from Second Cohort…
Yung Lyou, MD from the City of Hope speaks about High-throughput global transcriptional profiling to identify the STAT3 signaling pathway…
Kenny Chin, BS of the Icahn School of Medicine at Mount Sinai speaks about the ASTRO 2020 abstract 4021 Clinical…
Petros Grivas, MD, Ph.D. of the University of Washington; Fred Hutchinson Cancer Research Center speaks about the ESMO 2020 abstract…